- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04202276
The Study of Nutrition of Children and Adolescents With GERD
January 25, 2022 updated by: Sergey Morozov, Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
This trial is to study the aspects of nutrition in children and adolescents with GERD compared to the sex and age-matched control group
Study Overview
Detailed Description
The aim of the study is to assess the differences in nutrition of pediatric patients with GERD compared to the control group.
The secondary aim is to study possible associations of the data on nutritional habits revealed with the use of food frequency questionnaire (FFQ) and the data of 24-hours oesophageal pH-impedance examination.
Study Type
Interventional
Enrollment (Actual)
219
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Moscow, Russian Federation, 115446
- Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 17 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Willingness to participate (written informed consent and consent from parents or legal representative according to the local law);
- Age 6 to 17 years old inclusive,
- Possibility to assess symptoms, data of the medical history and receive answers to the questions about usual diet.
Exclusion Criteria:
- history of abdominal surgery;
- presence of varicose veins of the stomach and/or the oesophagus either in medical history or found during the study;
- inability to tolerate at least one of the invasive procedures or lacking data of the other instrumental examinations required by protocol;
- general condition of the patient making impossible to perform all the examinations or when performing the procedures is not safe and reasonable based on the opinion of the investigator that it may exacerbate the disease flow or put the patient at risk;
- intake of medications which may influence the clinical and instrumental data, including, but not limited to: non-steroid anti-inflammatory agents, glucocorticosteroids (except for skin products, if they were used for 2 weeks or less at the time of inclusion into the study), medications affecting adrenergic, acetylcholine receptors, antidepressants, tranquillizers, sedatives, those with known local irritant effect on the gastrointestinal tract mucosa; the use of proton pump inhibitors and H2 receptors blockers are not allowed during the study, a wash-out period for at least 2 weeks is necessary before the enrolment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Patients with GERD
The data of Food frequency questionnaire (FFQ), 24-hours oesophageal pH-impedance examination, GERD-Q questionnaire to be performed in children and adolescents with GERD.
|
Food frequency questionnaire to investigate differences in diet of children and adolescents with GERD compared to the age- and sex matched control group.
|
|
OTHER: Control group
The same examinations as in experimental group are to be performed in patients of the control group (no GERD according to the results of the examination): Food frequency questionnaire (FFQ), 24-hours oesophageal pH-impedance examination, GERD-Q questionnaire.
|
Food frequency questionnaire to investigate differences in diet of children and adolescents with GERD compared to the age- and sex matched control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Energy value of the ration
Time Frame: An average of 1 year
|
value of mean daily consumption of the energy by food frequency questionnaire, kcal/day
|
An average of 1 year
|
|
total fat consumption
Time Frame: An average of 1 year
|
value of mean daily consumption of fats by food frequency questionnaire, G/day
|
An average of 1 year
|
|
total carbohydrate consumption
Time Frame: An average of 1 year
|
value of mean daily consumption of carbohydrates, by food frequency questionnaire, G/day
|
An average of 1 year
|
|
total protein consumption
Time Frame: An average of 1 year
|
value of mean daily consumption of protein by food frequency questionnaire, G/day
|
An average of 1 year
|
|
Dietary fibre consumption
Time Frame: An average of 1 year
|
value of mean daily consumption of dietary fibre, by food frequency questionnaire, G/day
|
An average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total number of gastroesophageal refluxes
Time Frame: 24-hours
|
This measure is to be obtained by 24-hours oesophageal pH-impedance study
|
24-hours
|
|
Number of acid gastroesophageal refluxes
Time Frame: 24-hours
|
This measure is to be obtained by 24-hours oesophageal pH-impedance study
|
24-hours
|
|
Number of weak-acid gastroesophageal refluxes
Time Frame: 24-hours
|
This measure is to be obtained by 24-hours oesophageal pH-impedance study
|
24-hours
|
|
Number of high gastroesophageal refluxes
Time Frame: 24-hours
|
This measure is to be obtained by 24-hours oesophageal pH-impedance study
|
24-hours
|
|
Acid exposure time
Time Frame: 24-hours
|
This measure is to be obtained by 24-hours oesophageal pH-impedance study
|
24-hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Dmitriy B Nikityuk, Professor, Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
- Study Chair: Tatiana Strokova, Professor, Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2017
Primary Completion (ACTUAL)
June 30, 2019
Study Completion (ACTUAL)
December 31, 2021
Study Registration Dates
First Submitted
December 15, 2019
First Submitted That Met QC Criteria
December 16, 2019
First Posted (ACTUAL)
December 17, 2019
Study Record Updates
Last Update Posted (ACTUAL)
February 8, 2022
Last Update Submitted That Met QC Criteria
January 25, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAA-А19-119041090031-7
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data may be shared by the request.
No personal data of the participants is a subject for sharing.
IPD Sharing Time Frame
upon study completion.
Available for 2 years according to the local low
IPD Sharing Access Criteria
by request
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on GERD
-
Baylor Research InstituteRecruiting
-
Ohio State UniversityCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalRecruiting
-
Cinclus Pharma Holding ABCompleted
-
Korea United Pharm. Inc.CompletedGERDKorea, Republic of
-
Korea United Pharm. Inc.Completed
-
Chong Kun Dang PharmaceuticalUnknown
-
Turku University HospitalCompleted
Clinical Trials on diet assessment
-
Penn State UniversityAmerican Heart AssociationCompletedCardiovascular Diseases | Diet Modification | Health Promotion | Preventive Medicine | NutritionUnited States
-
Boston Medical CenterUniversity of Rhode IslandCompleted
-
Oregon Health and Science UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsNot yet recruitingPropionic Aciduria | Urea Cycle Disorder | Methylmalonic Acidemia | Maple Syrup Urine Disease
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingLymphomaUnited States
-
Virginia Commonwealth UniversityWithdrawnMalignant Childhood Neoplasm | Childhood Hodgkin Lymphoma | Childhood Brain Tumor | Childhood Non-Hodgkin Lymphoma
-
Fondazione del Piemonte per l'OncologiaRecruitingColorectal Cancer | Colon Cancer | Rectal CancersItaly
-
Universidad de La FronteraUniversity of ChileRecruitingHeart Failure NYHA Class II | Heart Failure NYHA Class IIIChile
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceCompletedType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Fred Hutchinson Cancer CenterBreast Cancer Research FoundationCompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Jonsson Comprehensive Cancer CenterKate Farms IncActive, not recruitingLocally Advanced Head and Neck CarcinomaUnited States